NCT05201014View on ClinicalTrials.gov

Cancer Survivor Cardiomyopathy Detection

Active, not recruitingOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

March 3, 2022

Primary Completion Date

September 20, 2026

Study Completion Date

September 20, 2026

Conditions
Cardiovascular DiseasesCancer
Interventions
DIAGNOSTIC_TEST

NT-pro-BNP

Blood draw

DIAGNOSTIC_TEST

Electrocardiogram

electrodes are placed on certain spots and a reading obtained to measure the voltage of the heart

DIAGNOSTIC_TEST

Echocardiogram

medical imaging of the heart

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Florida Heart Research Institute

OTHER

lead

Mayo Clinic

OTHER